arotinolol has been researched along with Hypertension, Pulmonary in 2 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, M | 1 |
| Sato, N | 1 |
| Asai, K | 1 |
| Takano, T | 1 |
| Mizuno, K | 1 |
| Nakamura, K | 1 |
| Fujio, H | 1 |
2 other studies available for arotinolol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Disease Models, | 2009 |
Are adrenergic receptor blockers effective or contraindicated in pulmonary arterial hypertension?
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Contraindications; Disease Progr | 2009 |